Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin
Crossref DOI link: https://doi.org/10.1186/s12894-017-0216-4
Published Online: 2017-04-13
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tijnagel, Marloes J.
Scheepe, Jeroen R.
Blok, Bertil F. M.
Funding for this research was provided by:
Astellas Pharma Europe